Molecular pathways of angiogenesis inhibition.


A large body of evidence now demonstrates that angiostatic therapy represents a promising way to fight cancer. This research recently resulted in the approval of the first angiostatic agent for clinical treatment of cancer. Progress has been achieved in decrypting the cellular signaling in endothelial cells induced by angiostatic agents. These agents… (More)


Cite this paper

@article{Tabruyn2007MolecularPO, title={Molecular pathways of angiogenesis inhibition.}, author={S{\'e}bastien P. Tabruyn and Arjan W. Griffioen}, journal={Biochemical and biophysical research communications}, year={2007}, volume={355 1}, pages={1-5} }